ULF wins RK Dixon $5,000 Make My Non-Profit Run Better award!
As announced at our annual meeting in Baltimore, we are now soliciting grant applications to support research in the leukodystrophies. Applications will be accepted now through October 15, 2014. All competitive applications will be reviewed by an expert committee for scientific merit, feasibility and potential contribution toward advancing the understanding and treatment of leukodystrophies. The maximum $35,000.00 grant award includes up to 10% of the requested funds for indirect costs, i.e. direct costs + indirect costs = $35,000.00. We anticipate funding one grant for up to $35,000.00 total costs (including indirect costs). Funding will be awarded by December 31, 2014 and extend for one year. Researchers must use the ULF Research Grant Application Template listed below and submit applications to our office electronically (email@example.com). It is expected that the research supported by this grant will be presented at a future ULF Scientific meeting. ULF Research Grant Application Template
Our 2014 Annual Benefit Drawing is underway. To see the letter, please click here: 2014 Benefit Drawing Letter To print additional entry forms, please click here: 2014 Benetif Drawing Tickets
We are pleased to announce that the $25,000.00 CADASIL Research Grant is being awarded to Fabrice Dabertrand, Ph.D. of the University of Vermont College of Medicine.
The MLD Natural History Study is seeking to improve the understanding of MLD and its progression in children under 12, in an effort to advance future treatment options. The study provides families with the opportunity to connect directly with doctors who specialize in MLD and to contribute to research that may benefit the MLD community at-large. Additional information about the Natural History study can be found at www.unitedformld.com , www.shiretrials.com, or www.clinicaltrials.gov.
Alexander Disease Research Update 2014 LIVE WEBINAR Please join Albee Messing, VMD, PhD, Professor of Neuropathology, Department of Comparative Biosciences, University of Wisconsin-Madison for his live webinar presentation on Saturday, March 8th, 2014 at 10:00 a.m. CST. Please click here to view the program information: March 8 2014 Alexander Disease Update Webinar-140308-Combined Flyer
The 2013 Annual Benefit Drawing Winners are: Mary Knapp from New Jersey won the one week stay at Orange Lake/Disney in Florida Donna Arnold from Michigan won the one week stay at Christmas Mountain in Wisconsin Dells, Wisconsin and Gloria LeDesma from Arizona won the handmade queen size quilt made by Anita Lewis.
For more information, please visit: www.Starbeamstudy.com This website is an interim site where parents and others can learn about the Starbeam Study and gene therapy. A newer version of the Starbeam Study website will eventually be used to recruit study participants. Therefore, it requires study site institutional review board approvals before it can be activated. The IRB-approved version of the website, which should be accessible before the end of the year, will then reflect that the study is open and enrolling participants.
Please click on the links below to view the instructions and print the grant application for submission, the application is due on or before February 1, 2014. Instructions: CADASIL GRANT APPLICATION INSTRUCTIONS Grant Application Form: CADASIL GRANT APPLICATION
Gene Therapy Study Seeking Participants with Childhood Cerebral Adrenoleukodystrophy An international clinical research study, called the Starbeam Study, is now enrolling boys, aged 17 and younger, who have been diagnosed with Childhood Cerebral Adrenoleukodystrophy (CCALD). CCALD symptoms usually occur in early childhood and progress rapidly, if untreated, ultimately leading to death. CCALD is a rare, genetic brain disorder that occurs when a broken gene, the ABCD-1 gene, does not work properly. Boys with CCALD do not produce any or enough of the adrenoleukodystrophy protein, or ALDP. Without enough ALDP, cells in the brain collect and store too many very long chain fatty acids. These fatty acids are harmful to brain cells and can trigger inflammation, which is responsible for the breakdown of myelin, a protective sheath that surrounds and protects the nerve cells. As the myelin breaks down, the brain can no longer function properly. When untreated, this